Baselining the Buzz. Trastuzumab-HER2 Affinity, and Beyond!
Chinery, L.; Hummer, A. M.; Mehta, B. B.; Akbar, R.; Rawat, P.; Slabodkin, A.; Le Quy, K.; Lund-Johansen, F.; Greiff, V.; Jeliazkov, J. R.; Deane, C. M.
Show abstract
Strong antibody-antigen binding is the primary consideration when developing an efficacious therapeutic antibody. In recent years, much work has been devoted to applying complex machine learning models to this cause, yet simple baselines are often lacking. Here, we show that the widely used sequence alignment method, BLOSUM, can yield diverse, binder-enriched libraries from a single starting antibody. Using Trastuzumab-HER2 as a model system, we experimentally validated 720 novel designs generated with five different computational methods using surface plasmon resonance. The BLOSUM substitution matrix outperformed all four deep learning design approaches tested, achieving an estimated minimum binder enrichment of 12.5% and producing nine sub-nanomolar binders. These results underscore the importance of comparing against simple baselines and set a benchmark to guide future computational antibody library design. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=141 SRC="FIGDIR/small/586756v2_ufig1.gif" ALT="Figure 1"> View larger version (32K): org.highwire.dtl.DTLVardef@1597ee9org.highwire.dtl.DTLVardef@9af4b6org.highwire.dtl.DTLVardef@1380e61org.highwire.dtl.DTLVardef@1380d29_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 5 journals account for 50% of the predicted probability mass.